Published in World J Surg on February 20, 1992
Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg (2002) 1.87
Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease. Ann Surg (1992) 1.57
Reoperation for parathyroid adenoma: a contemporary experience. Surgery (2009) 1.50
Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg (2000) 1.45
Cost-effectiveness of preoperative localization studies in primary hyperparathyroid disease. Ann Surg (1994) 1.40
Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg (2004) 1.32
Imaging techniques in parathyroid surgery for primary hyperparathyroidism. Am J Otolaryngol (2011) 1.20
Thoracoscopic removal of mediastinal hyperfunctioning parathyroid glands: personal experience and review of the literature. World J Surg (2008) 1.11
Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg (2003) 1.08
Primary hyperparathyroidism: an overview. Int J Endocrinol (2011) 1.06
1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg (2007) 1.05
Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg (1993) 1.03
Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe. World J Surg (2004) 1.02
Do giant parathyroid adenomas represent a distinct clinical entity? Surgery (2013) 1.00
Ultrasound-guided unilateral neck exploration for sporadic primary hyperparathyroidism: is it worthwhile? Ann R Coll Surg Engl (1998) 1.00
Focused versus conventional parathyroidectomy for primary hyperparathyroidism: a prospective, randomized, blinded trial. Langenbecks Arch Surg (2008) 1.00
Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. World J Surg (2004) 0.97
Video-assisted bilateral neck exploration in patients with primary hyperparathyroidism and failed localization studies. World J Surg (2010) 0.88
Thoracoscopic removal of ectopic mediastinal parathyroid adenoma. Korean J Thorac Cardiovasc Surg (2014) 0.87
Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg (2004) 0.86
Reoperations for primary hyperparathyroidism--improvement of outcome over two decades. Langenbecks Arch Surg (2012) 0.85
Direct, minimally invasive adenomectomy for primary hyperparathyroidism: An alternative to conventional neck exploration? Ann Surg (2000) 0.85
Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism? World J Surg (2008) 0.85
Comparative analysis of clonality and pathology in primary and secondary hyperparathyroidism. Virchows Arch (1997) 0.85
Endoscopic parathyroid surgery: results of 365 consecutive procedures. World J Surg (2004) 0.85
Technetium-99m 2-methoxyisobutyl isonitrile-scintigraphy: preoperative and intraoperative guidance for primary hyperparathyroidism. World J Surg (2004) 0.84
Endoscopic parathyroidectomy: why and when? World J Surg (2008) 0.83
The results of surgery for mediastinal parathyroid tumors: a comparative study of 63 patients. Langenbecks Arch Surg (2010) 0.82
Scandinavian Quality Register for Thyroid and Parathyroid Surgery: audit of surgery for primary hyperparathyroidism. Langenbecks Arch Surg (2006) 0.82
Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy. World J Surg (2013) 0.81
Bilateral oblique approach to parathyroid glands. Ann Surg (2000) 0.80
Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay. Ann Surg (2002) 0.80
Normalization of 2-week postoperative parathyroid hormone values in patients with primary hyperparathyroidism: four-gland exploration compared to focused-approach surgery. World J Surg (2010) 0.79
Minimally invasive endoscopic-assisted parathyroidectomy for primary hyperparathyroidism. Surg Endosc (2003) 0.79
A new classification of positive sestamibi and ultrasound scans in parathyroid localization. World J Surg (2012) 0.78
Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg (2012) 0.77
Unilateral surgery for hyperparathyroidism: indications, limits, and late results--new philosophy or expensive selection without improvement of surgical results? World J Surg (2004) 0.76
Minimally invasive parathyroid surgery. Ochsner J (2000) 0.75
Surgery of parathyroid. Indian J Surg (2010) 0.75
Minimally invasive parathyroid exploration for solitary adenoma. Initial experience with an open, 'short incision' approach. Ulster Med J (2008) 0.75
Preoperative localization of hyperfunctioning parathyroid glands with 4D-CT. Eur Arch Otorhinolaryngol (2015) 0.75
A case of acute psychosis in an adolescent male. Case Rep Endocrinol (2014) 0.75
Intra-operative parathyroid hormone assay for simplified localization of parathyroid adenomas. J R Soc Med (1996) 0.75
Intraoperative scintigraphy using a large field-of-view portable gamma camera for primary hyperparathyroidism: initial experience. Biomed Res Int (2015) 0.75
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37
Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab (2001) 3.19
Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery (2001) 2.50
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery (1987) 2.42
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06
Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery (1992) 2.06
Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg (1996) 1.88
Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. Surgery (1994) 1.72
Anastomotic ulceration following subtotal and total pancreatectomy. Ann Surg (1979) 1.69
Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol (1999) 1.69
Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomy. J Gastrointest Surg (2006) 1.68
Reexploration for symptomatic hematomas after cervical exploration. Surgery (2001) 1.66
Survival after surgical treatment for primary hyperparathyroidism. Surgery (1997) 1.66
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg (2001) 1.64
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol (2001) 1.63
Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery (2000) 1.63
Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med (2001) 1.58
Primary thyroid lymphoma. Semin Oncol (1999) 1.57
Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery (1990) 1.47
Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg (1990) 1.45
Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery (1988) 1.44
Incidentally discovered adrenal tumors: an institutional perspective. Surgery (1991) 1.43
Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery (1994) 1.41
Are concomitant surgical procedures acceptable in patients undergoing cervical exploration for primary hyperparathyroidism? Mayo Clin Proc (1991) 1.41
Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery (1997) 1.40
Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg (1996) 1.39
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience. Mayo Clin Proc (1994) 1.38
Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma. Surgery (1991) 1.38
Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization. AJR Am J Roentgenol (1986) 1.37
Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med (1998) 1.36
Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery (1998) 1.35
Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery (2000) 1.32
Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg (1990) 1.29
Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol (1987) 1.27
Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg (2002) 1.26
Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc (1992) 1.22
Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg (1999) 1.21
Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol (2003) 1.20
Are patients with multiple endocrine neoplasia type I prone to premature death? World J Surg (2000) 1.18
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery (1988) 1.17
Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. AJR Am J Roentgenol (1994) 1.17
Selective operative cholangiography. Appropriate management for laparoscopic cholecystectomy. Arch Surg (1995) 1.14
Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc (1990) 1.14
Adrenocortical carcinoma: surgical progress or status quo? Arch Surg (2001) 1.14
Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest (1991) 1.13
Congenital lobar emphysema. Can J Anaesth (1990) 1.12
Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc (1985) 1.12
Intraoperative topical tetracycline sclerotherapy following mastectomy: a prospective, randomized trial. J Surg Oncol (2000) 1.12
Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest (1991) 1.11
Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg (1984) 1.11
Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery (1992) 1.10
Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer (1990) 1.09
Fine-needle aspiration of the breast. Mayo Clin Proc (1986) 1.08
Clinical management of persistent and/or recurrent primary hyperparathyroidism. World J Surg (1986) 1.07
Localization of pancreatic insulinoma: comparison of pre- and intraoperative US with CT and angiography. Radiology (1988) 1.07
Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg (1995) 1.06
Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome. Surgery (1994) 1.05
Toxic megacolon: ultimate fate of patients after successful medical management. Am J Surg (1984) 1.04
Occult functioning insulinomas: which localizing studies are indicated? Surgery (1992) 1.03
Pheochromocytoma--continuing evolution of surgical therapy. Surgery (1993) 1.02
Early postoperative morbidity after surgical treatment of thyroid carcinoma. Surgery (1987) 1.01
Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg (1990) 1.01
Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab (1997) 1.01
Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms. Endocr Pathol (2001) 0.99
Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg (1999) 0.98
Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid. World J Surg (1988) 0.97
Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Ann Intern Med (1984) 0.97
The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma. Cancer (1992) 0.97
Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Arch Surg (1998) 0.96
Ectopic ACTH syndrome. Diagnostic and therapeutic aspects. Am J Surg (1985) 0.96
Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc (1992) 0.96
Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer (2000) 0.96
Insulinoma in a patient with NIDDM. Diabetes Care (1993) 0.95
Hyperfunctioning supernumerary parathyroid glands. An occasional cause of hyperparathyroidism. Mayo Clin Proc (1982) 0.95
Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery (1995) 0.95
Benign Hürthle cell tumors of the thyroid: a diagnosis to be trusted? World J Surg (1988) 0.94
Intraoperative real-time ultrasonographic localization of pancreatic insulinoma: initial experience. J Ultrasound Med (1983) 0.94
Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma. Mayo Clin Proc (1985) 0.93
Reoperative insulinomas, 1927 to 1992: an institutional experience. Surgery (1993) 0.93
Urinary hydroxyproline and prognosis in human breast cancer. Br J Surg (1984) 0.93
Islet cell carcinoma of the pancreas. World J Surg (1996) 0.93
Can adrenal incidentalomas be safely observed? World J Surg (1998) 0.93
Pheochromocytoma: nuclear deoxyribonucleic acid patterns studied by flow cytometry. Surgery (1986) 0.92
Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab (2001) 0.92
Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Mod Pathol (2000) 0.91
Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg (1995) 0.90
Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery (1999) 0.90
Hürthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg (1992) 0.89
Non-Hodgkin's lymphoma of the thyroid: is more than biopsy necessary? World J Surg (1992) 0.89
Adrenal surgery for hypercortisolism--surgical aspects. Surgery (1995) 0.88
Medullary thyroid carcinoma: role of high-resolution US. Radiology (1987) 0.88
US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology (1988) 0.88
The Zollinger-Ellison syndrome. A collective surgical experience. Ann Surg (1992) 0.88
The current role of parathyroid cryopreservation and autotransplantation in parathyroid surgery: an institutional experience. Surgery (1997) 0.87
Leiomyosarcoma of the stomach: determinants of long-term survival. Mayo Clin Proc (1992) 0.87
High-resolution parathyroid sonography. AJR Am J Roentgenol (1982) 0.87